According to Foresight News, the decentralized research (DeSci) platform Bio Protocol will launch its first BioAgent sales project, Aubrai. The total supply of Aubrai is 2 million, of which 20% will be used for sales, 6% will be allocated to the liquidity pool, 15% will be allocated to the treasury, 20.1% will be allocated to initial funders, 10% will be allocated to LEVF, 22% will be allocated to VitaDAO, and 6.9% will be allocated to Bio Protocol. The token TGE will take place on August 25.
Aubrai is a decentralized scientific intelligence agent developed jointly by VitaDAO and BIO, aimed at combating human aging.
